Sort
40,608 grants matching “prostate cancer”
AN INNOVATIVE APPROACH TO EXTINGUISH ANDROGEN RECEPTOR (AR) AXIS SIGNALING IN PROSTATE CANCER
$356,617Baylor College Of Medicine · · FY2015 · Department of Defense
SURVEY CORE
$356,572Brenda Sirovich · Dartmouth College · P01 · FY2008 · AG
Training Program in Cancer Biology
$356,567Mary Elaine Reyland · University Of Colorado Denver · T32 · FY2018 · CA
GSTP1-induced S-glutathionylation in lung cancer
$356,564Adrianus (jos)l.j. Van Der Velden · University Of Vermont & St Agric College · R01 · FY2017 · CA
Hypoxia: Impact on Src Signaling and Prostate Cancer
$356,553Dietmar W Siemann · University Of Florida · R01 · FY2016 · CA
Design, Develop, Validate, and Implement Biomarkers for Clinical Investigations
$356,520Liang Cao · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy
$356,444Zheng-Rong Lu · Case Western Reserve University · R01 · FY2019 · CA
Role of CPT1A as a lysine succinyltransferase in tumorigenesis
$356,438Taro Hitosugi · Mayo Clinic Rochester · R01 · FY2022 · CA
UFM1 signaling in DNA damage response and cancer therapy
$356,438Zhenkun Lou · Mayo Clinic Rochester · R01 · FY2022 · CA
Regulation of pten tumor suppressive functions by C-tail phosphorylation.
$356,438Darren Baker · Mayo Clinic Rochester · R01 · FY2023 · CA
Mechanism of non-oncogene addiction
$356,438Mohammad Azam · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Regulation of pten tumor suppressive functions by C-tail phosphorylation.
$356,438Darren Baker · Mayo Clinic Rochester · R01 · FY2022 · CA
Mechanism and role of aberrant AR activity in castration-resistant prostate cancer
$356,438Haojie Huang · Mayo Clinic Rochester · R01 · FY2022 · CA
Community Engagement and Outreach Core
$356,370Carol Estwing Ferrans · University Of Illinois At Chicago · P60 · FY2013 · MD
The JAZF1 Gene and Type 2 Diabetes
$356,363Jeffrey Sklar · Yale University · R01 · FY2010 · DK
Interaction of germline and somatic changes in PCa progression
$356,359Wennuan Liu · Wake Forest University Health Sciences · R01 · FY2011 · CA
TARGETING N-MYC-DRIVEN CASTRATE-RESISTANT PROSTATE CANCER
$356,355Weill Medical College Of Cornell University · · FY2017 · Department of the Army
Identifying and Reducing Disparities in Patient-Reported Outcomes Among African American Prostate Cancer Survivors
$356,298Brian D Gonzalez · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Project 2 - Clinical translation
$356,266Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2016 · CA
Genome-wide scan for genetic variants associated with early-onset prostate cancer
$356,262Kathleen A Cooney · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2005 · NS
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2004 · NS
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2002 · NS
Pten regulation of growth and neoplasia in the brain
$356,250St. Jude Children'S Research Hospital · R01 · FY2003 · NS
Towards selective androgen deprivation by targeting androgen activation of SRF
$356,196Hannelore Heemers · Roswell Park Cancer Institute Corp · R01 · FY2014 · CA